D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: Enhanced frequencies in psychostimulant-preferring polysubstance abusers

Biological Psychiatry

Volumn 40, Issue 8, 1996, Pages 776-784

  Persico, Antonio M ^a,e   Bird, Geoffrey ^a   Gabbay, Frances H ^b   Uhl, George R ^a,c,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NIDA Addiction Research Center   (United States)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

alcoholism; amphetamine; cocaine; dopamine D2 receptor; genetic association; substance abuse

Indexed keywords

AMPHETAMINE; COCAINE; DIAMORPHINE; DOPAMINE 2 RECEPTOR; OPIATE; PSYCHOSTIMULANT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETICS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBSTANCE ABUSE; ADDICTION; GENETIC MARKER; LIMBIC SYSTEM; MESENCEPHALON; METHODOLOGY; OPIATE ADDICTION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PSYCHOLOGICAL ASPECT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AMPHETAMINE; COCAINE; FEMALE; GENETIC MARKERS; HUMANS; LIMBIC SYSTEM; MALE; MESENCEPHALON; OPIOID-RELATED DISORDERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, DOPAMINE D2; SUBSTANCE-RELATED DISORDERS;

EID: 0030587624     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00483-1     Document Type: Article

References (45)

1. 2 receptor locus. Biol Psychiatry 34:204-209.
2. 2 receptor gene in alcoholism. JAMA 263:2055-2060.
3. Cadoret RJ, O'Gorman T, Troughton E, et al (1987): An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry 43:1131-1136.
4. Cohen J (1977): Statistical Power Analysis for the Behavioral Sciences, rev. ed., New York, NY: Academic Press.
5. Commings DE, MacMurray J, Johnson JP, et al (1993): The dopamine D2 receptor gene: A genetic risk factor in substance abuse. Drug Alc Depend 34:175-180.
6. Di Chiara G, Imperato A (1988): Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
7. Falk CT, Rubinstein P (1987): Haplotype relative risk: An easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 51:227-233.
8. 2 receptor gene in alcoholism or schizophrenia. JAMA 271:204-208.
9. 2 dopamine receptor gene and alcoholism. JAMA 269:1673-1677.
10. Gelernter J, Kranzler H, Satel S (1993b): No association between DRD2 alleles and cocaine abuse. College on Problems of Drug Dependence, Toronto, Canada, annual meeting, June 16.
11. George VT, Elston RC (1987): Testing the association between polymorphic markers and quantitative traits in pedigrees. Genet Epidemiol 4:193-201.
12. Goldman D, Dean M, Brown GL, et al (1993): DRD2 dopamine receptor genotype, linkage disequilibrium and alcoholism in American Indians and other populations. Alcohol Clin Exp Ther 17:199-204.
13. 2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 45:778-785.
14. 2 receptor gene. Genomics 10:527-530.
15. Hodge SE (1993): Linkage analysis versus association analysis: Distinguishing between two models that explain disease-marker associations. Am J Hum Genet 53:367-384.
16. Knapp M, Seuchter SA, Baur MP (1993): The Haplotype-Relative-Risk (HRR) method for analysis of association in nuclear families. Am J Hum Genet 52:1085-1093.
17. Kuhar MJ, Ritz MC, Boja JW (1991): The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
18. Li T, Yang L, Wiese C, et al (1994): No association between alleles or genotypes at the dopamine transporter gene and schizophrenia. Psychiatry Res 52:17-23.
19. Luthar SS, Anton SF, Merikangas KR, et al (1992): Vulnerability to substance abuse and psychopathology among siblings of opioid abusers. J Nerv Ment Dis 180:153-161.
20. Noble EP (1993): The D2 dopamine receptor gene: A review of association studies in alcoholism. Behav Genet 23:119-129.
21. 2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 33:271-285.
22. 2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48:648-654.
23. 2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. Hum Hered 43:209-218.
24. 2 receptor gene (DRD2). Nucleic Acids Res 19:6977.
25. Pedersen NL (1984): Multivariate analysis of familial and non-familial influences for commonality in drug use. Drug Alcohol Depend 14:67-74.
26. 2 receptor gene variants and substance abuse liability. Seminars Neurosci 5:377-382.
27. Persico AM, Vandenbergh DJ, Smith SS, et al (1993b): Dopamine transporter gene markers are not associated with polysubstance abuse. Biol Psychiatry 34:265-267.
28. 2 receptor gene TaqI "A" locus map including "A4" variant: relevance for alcoholism and drug abuse. Drug Alcohol Depend 31:229-234.
29. Pettit HO, Ettenberg A, Bloom FE, et al (1984): Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84:167-173.
30. Pickens RW, Svikis DS, McGue M, et al (1991): Heterogeneity in the inheritance of alcoholism: A study of male and female twins. Arch Gen Psychiatry 48:19-28.
31. Pulvirenti L, Maldonado R, Koob GF (1992): NMDA-receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat. Brain Res 594:327-330.
32. Regier DA, Farmer ME, Rae DS, et al (1990): Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 264:2511-2518.
33. Sambrook J, Fritsch EF, Maniatis T (1989): Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
34. Sano A, Kondoh K, Kakimoto Y, Kondo I (1993): A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 91:405-406.
35. 2 receptor TaqI B1 RFLP appears more frequently in polysubstance abusers. Arch Gen Psychiatry 49:723-727.
36. 2 dopamine receptor TaqI A or B gene marker frequencies in incarcerated substance abusers. Biol Psychiatry 33:845-848.
37. 2 dopamine receptor locus (DRD2) in alcoholics and controls. Genomics 19:12-20.
38. Surratt CK, Persico AM, Yang XD, et al (1993): A human synaptic vesicle monoamine transporter cDNA predicts post-translational modifications, reveals chromosome 10 gene location and identifies TaqI RFLPs. FEBS Lett 318:325-330.
39. Swift M, Kupper LL, Chase CL (1990): Effective testing of gene-disease associations. Am J Hum Genet 47:266-274.
40. 2 receptor gene alleles in substance abuse. Arch Gen Psychiatry 49:157-160.
41. 2 receptor genes. Trends Neurosci 16:83-88.
42. Uhl GR, Elmer G, Labuda M, Pickens RW (1995): Genetic influences in drug abuse. In Bloom F.E., and Kupfer F. (eds): Psychopharmacology: The Fourth Generation of Progress, New York, NY: Raven Press.
43. Vaccarino FJ, Bloom FE, Koob GF (1985): Blockage of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat. Psychopharmacology 85:37-42.
44. Vandenbergh DJ, Persico AM, Hawkins AL, et al (1992): Human dopamine transporter gene maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106.
45. Wise RA, Rompre PP (1989): Brain dopamine and reward. Annu Rev Psychol 40:191-225.